Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Y Jones

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer|March 8, 2017
Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapyMariko Sato, Jillian R Gunther, Anita Mahajan, et al.
Neuro-Oncology|February 13, 2019
Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapyEthan B Ludmir, Anita Mahajan, Arnold C Paulino, et al.
Journal of the American College of Radiology : JACR|May 5, 2018
ACR Appropriateness Criteria<sup>®</sup> Headache-Child, Laura L Hayes, Susan Palasis, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Scoliosis-Child, Jeremy Y Jones, Gaurav Saigal, et al.
Journal of the American College of Radiology : JACR|November 6, 2018
ACR Appropriateness Criteria<sup>®</sup> Sinusitis-Child, Aylin Tekes, Susan Palasis, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Back Pain-Child, Timothy N Booth, Ramesh S Iyer, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Suspected Spine Trauma-Child, Nadja Kadom, Susan Palasis, et al.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer|March 8, 2017
Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapyMariko Sato, Jillian R Gunther, Anita Mahajan, et al.
Neuro-Oncology|February 13, 2019
Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapyEthan B Ludmir, Anita Mahajan, Arnold C Paulino, et al.
Journal of the American College of Radiology : JACR|May 5, 2018
ACR Appropriateness Criteria<sup>®</sup> Headache-Child, Laura L Hayes, Susan Palasis, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Scoliosis-Child, Jeremy Y Jones, Gaurav Saigal, et al.
Journal of the American College of Radiology : JACR|November 6, 2018
ACR Appropriateness Criteria<sup>®</sup> Sinusitis-Child, Aylin Tekes, Susan Palasis, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Back Pain-Child, Timothy N Booth, Ramesh S Iyer, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Suspected Spine Trauma-Child, Nadja Kadom, Susan Palasis, et al.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Pageof 3